New patent for Galderma Labs drug AKLIEF

Copyright © DrugPatentWatch. Originally published at https://www.drugpatentwatch.com/blog/

Annual Drug Patent Expirations for AKLIEF
Annual Drug Patent Expirations for AKLIEF

Aklief is a drug marketed by Galderma Labs Lp and is included in one NDA. It is available from one supplier. There are five patents protecting this drug.

AKLIEF drug price trends.

This drug has fifty-six patent family members in twenty-eight countries.

The generic ingredient in AKLIEF is trifarotene. One supplier is listed for this compound. Additional details are available on the trifarotene profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at
DrugPatentWatch - Make Better Decisions
Scroll to Top